Early statin treatment following acute myocardial infarction and 1-year survival

JAMA

Volumn 285, Issue 4, 2001, Pages 430-436

  Stenestrand, Ulf ^a   Wallentin, Lars ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SCORING SYSTEM; SURVIVAL RATE; SWEDEN;

EID: 0035941512     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.4.430     Document Type: Article

References (22)

1. Randomised trials of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
4. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
5. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
6. Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events
7. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
8. Early HMG-CoA reductase inhibition in acute coronary syndromes: Preliminary data of the Pravastatin in Acute Ischaemic Syndromes Study (PAlS)
9. Effects of low dose pravastatin therapy on endothelium generated mediators and thrombotic tendency in patients with hypercholesterolaemia
10. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIR-ACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction
11. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project
12. Regression models and life-tables
13. Propensity scores
14. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction
15. Do "America's best hospitals" perform better for acute myocardial infarction?
16. Differences in management of heart attack patients between metropolitan and regional hospitals in the Hunter region of Australia
17. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention
18. ACC/AHA guidelines for the management of patients with acute myocardial infarction
19. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
20. Long-term effects of pravastatin on plasma concentration of C-reactive protein
21. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
22. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability